Locating Pfizer’s corporate headquarters for their new Center for Therapeutic Innovation [CTI] in the Center for Life Science | Boston, in the heart of the Longwood Medical Area, represents their strategic goal of addressing translational medicine by accelerating research and drug development.
"Pfizer created CTI to facilitate the transition of exciting scientific discoveries from the academic lab into clinical trials, to expedite the prospects of making important new medicines available to patients."
Director of Biotech Operations
Centers for Therapeutic Innovation (CTI), Pfizer
BSL 2 Biocontainment